Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048230
Status:
COMPLETED
Last Update Posted:
2012-01-13
First Post:
2002-10-28
Brief Title:
PS-341 VELCADE Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Millennium Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
2004-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-12
Completion Date Type:
ACTUAL
First Submit Date:
2002-10-28
First Submit QC Date:
October 29 2002
Study First Post Date:
2002-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-01-12
Last Update Post Date:
2012-01-13
Last Update Post Date Type:
ESTIMATED